47774
维生素 (K2)
analytical standard
别名:
维生素 K2, 四烯甲萘醌, 甲萘醌 4
登录 查看组织和合同定价。
选择尺寸
关于此项目
经验公式（希尔记法）:
C31H40O2
化学文摘社编号:
分子量:
444.65
UNSPSC Code:
12164500
PubChem Substance ID:
MDL number:
NACRES:
NA.24
产品名称
维生素 (K2), analytical standard
InChI
1S/C31H40O2/c1-22(2)12-9-13-23(3)14-10-15-24(4)16-11-17-25(5)20-21-27-26(6)30(32)28-18-7-8-19-29(28)31(27)33/h7-8,12,14,16,18-20H,9-11,13,15,17,21H2,1-6H3/b23-14+,24-16+,25-20+
SMILES string
C\C(C)=C\CC\C(C)=C\CC\C(C)=C\CC\C(C)=C\CC1=C(C)C(=O)c2ccccc2C1=O
InChI key
DKHGMERMDICWDU-GHDNBGIDSA-N
grade
analytical standard
CofA
current certificate can be downloaded
feature
standard type fat soluble vitamin
packaging
ampule of 100 mg
technique(s)
HPLC: suitable
gas chromatography (GC): suitable
application(s)
pharmaceutical (small molecule)
vitamins, nutraceuticals, and natural products
format
neat
storage temp.
-10 to -25°C
Quality Level
正在寻找类似产品? 访问 产品对比指南
Application
有关合适仪器技术的更多信息，请参考产品的分析证书。如需进一步支持，请联系技术服务。
甲基萘醌可用作引用液相色谱串联质谱法测定人血浆中甲基萘醌的参比标准品。
General description
甲基萘醌 (K2)，一种维生素 K2 同系物，具有四个异戊二烯单元。有报道它能增强骨形成 ，对血液凝血因子的产生起至关重要的角色。
Other Notes
在我们的NMR在线平台ChemisTwin®上可以找到本品对应的数字化标准物质。您可使用ChemisTwin®上的数字等效品鉴定您的样品并进行定量分析（使用数字化外标）。可查看该物质的NMR谱图，只需点击几次鼠标，就能进行在线样品比对。欢迎点击了解更多，开启免费试用之旅。
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
Simple and sensitive determination of menatetrenone and its epoxide metabolite in human plasma.
Kang W, et al.
Journal of Pharmaceutical and Biomedical Analysis, 44(5), 1178-1182 (2007)
Effects of menatetrenone on bone loss induced by ovariectomy in rats.
Akiyama Y, et al.
Japanese Journal of Pharmacology, 62(2), 145-153 (1993)
Menatetrenone, a vitamin K2 analogue, inhibits hepatocellular carcinoma cell growth by suppressing cyclin D1 expression through inhibition of nuclear factor κ activation.
Ozaki I, et al.
Clinical Cancer Research, 13(7), 2236-2245 (2007)
Vitamin K2 (menatetrenone) inhibits bone loss induced by prednisolone partly through enhancement of bone formation in rats.
Hara K, et al.
Bone, 31(5), 575-581 (2002)
Mariko Ochiai et al.
Nephron. Clinical practice, 117(1), c15-c19 (2010-08-07)
A low level of intact parathyroid hormone (PTH) is an indicator of adynamic bone disease in hemodialysis patients, and is associated with a significant increase of all-cause mortality. Thus, effective treatment for adynamic bone disease is required. We previously investigated
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持